touchONCOLOGY joins Dr Markus Joerger (St. Gallen Cancer Center, Switzerland) at ESMO 2021 to discuss the outcome and prognostic factors of COVID-19 infection in cancer patients.
1. What were the objectives of the SAKK 80/20 study? (00:15-00:50)
2. Could you give us a brief overview of the patient population of this study? (00:50-02:14)
3. What were the findings in terms of outcomes of COVID-19 infection in cancer patients?(02:14-03:57)
4. What conclusions can be made from these findings? (03:57-04:49)
5. What questions remain unanswered and what future studies are needed? (04:49-05:43)
Disclosures: Markus Joerger has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson
Filmed in coverage of the ESMO 2021 Annual Meeting.
Share this Video
Related Videos In COVID-19
Pamela Kearns: Leading SIOP Europe during the COVID-19 Pandemic
touchONCOLOGY spoke to Professor Pamela Kearns (University of Birmingham, UK) to discuss her experience as President of SIOP Europe during the COVID-19 pandemic, and the biggest achievements of the European paediatric oncology community during that time. Questions How would you describe your experience as the SIOP Europe President (2019–21) and how the COVID-19 pandemic influenced […]
Morgan Rouprêt, ESOU22: What Have We Learned From the COVID-19 Pandemic?
touchONCOLOGY are joined by the EAU Section of Oncological Urology (ESOU) Chairman Professor Morgan Rouprêt to discuss what we have learned from the COVID-19 pandemic, how this has impacted the care of cancer patients and what we can do to move forward. Questions What was the impact of the COVID-19 pandemic on […]
Mark Lawler, European Cancer Summit 2021: Time To Act: COVID-19 & Cancer Campaign
We were delighted to catch up with Prof Mark Lawler to discuss the challenges that the COVID-19 pandemic has had on cancer care in Europe, and the key objectives and messages of the Time To Act: COVID-19 & Cancer campaign. Questions 1. What has been the impact of the COVID-19 pandemic on cancer screening and […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!